| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Eye and orbita (Neovascularization)Triamcinolone acetonideMyopiaVEGFAMD macular degeneration| 1 | 2008 | Two years follow-up outcome of verteporfin therapy for subfoveal choroidal neovascularization in pathologic myopia in Indian eyes. | 
| + | - | nl | Indian J Ophthalmol 56(6):465-8 (2008) |
| 2 | 1998 | Choroidal neovascular membrane. |
| + | - | nl | Indian J Ophthalmol 46(2):67-80 (1998) |
| 3 | 2006 | Ocular versus extraocular neovascularization: mirror images or vague resemblances. |
| + | - | nl | Invest Ophthalmol Vis Sci 47(2):462-74 (2006) |
| 4 | 1994 | Mechanisms of retinal and choroidal neovascularization. |
| + | - | nl | Invest Ophthalmol Vis Sci 35(12):3974-9 (1994) |
| 5 | 2009 | Early effects of intravitreal triamcinolone acetonide on inflammation and proliferation in human choroidal neovascularization. |
| + | - | nl | Arch Ophthalmol 127(3):275-81 (2009) |
| 6 | 2008 | Effect of bevacizumab on inflammation and proliferation in human choroidal neovascularization. |
| + | - | nl | Arch Ophthalmol 126(6):782-90 (2008) |
| 7 | 2006 | Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes. |
| + | - | nl | Arch Ophthalmol 124(6):815-23 (2006) |
| 8 | 2005 | [PPAR gamma: a novel pharmacological target against retinal and choroidal neovascularization]. |
| + | - | nl | J Fr Ophtalmol 28(3):326-30 (2005) |
| 9 | 2006 | Vascular endothelial growth factor biology: clinical implications for ocular treatments. |
| + | - | nl | Br J Ophthalmol 90(12):1542-7 (2006) |
| 10 | 2006 | Verteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranes. |
| + | - | nl | Br J Ophthalmol 90(8):1034-9 (2006) |
| 11 | 2006 | Choroidal neovascularisation and atrophy. |
| + | - | nl | Br J Ophthalmol 90(4):398-9 (2006) |
| 12 | 2005 | Choroidal neovascularisation in pathological myopia: an update in management. |
| + | - | nl | Br J Ophthalmol 89(11):1522-8 (2005) |
| 13 | 2005 | Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation. |
| + | - | nl | Br J Ophthalmol 89(9):1109-11 (2005) |
| 14 | 1997 | Role of vascular permeability factor/vascular endothelial growth factor in eye disease. |
| + | - | nl | Br J Ophthalmol 81(6):501-12 (1997) |
| 15 | 1992 | Detection of subpigment epithelial neovascularisation in cases of retinal pigment epithelial detachments: a review of the Moorfields treatment trial. |
| + | - | nl | Br J Ophthalmol 76(1):8-10 (1992) Pagliarini S |
| 16 | 1986 | Neovascularisation. |
| + | - | nl | Br J Ophthalmol 70(3):161 (1986) |
| 17 | 2010 | Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications. | 
| + | - | nl | Mediators Inflamm 2010(-):- (2010) |
